Holywood, United Kingdom

Deborah Leigh Caldwell

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Deborah Leigh Caldwell: A Pharmaceutics Innovator with Promising Patents

Introduction:

Deborah Leigh Caldwell, an esteemed inventor and scientist based in Holywood, Great Britain, has made noteworthy contributions to the field of pharmaceutics. With two patents to her name, Deborah has demonstrated her expertise in developing innovative dosage forms for 5-aminosalicylic acid capsules. Her latest patents feature enterically coated tablets, revolutionizing drug delivery methods. Currently affiliated with Allergan Pharmaceuticals International Limited, Deborah collaborates with accomplished colleagues such as Emma Boyd and Catherine Coulter to push the boundaries of pharmaceutical innovation.

1. Background:

Deborah Leigh Caldwell possesses an impressive track record in the field of pharmaceutics. With a background in pharmacy, she has honed her skills over the years, focusing on drug formulation and delivery systems. Working closely with esteemed colleagues at Allergan Pharmaceuticals International Limited, Deborah has consistently pushed for innovation and breakthrough solutions in the pharmaceutical industry.

2. Notable Patents:

Deborah's two patents, related to the 5-aminosalicylic acid capsule formulation, have gained attention in the industry for their novel approach to drug delivery. The first patent revolves around a dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid, with each tablet being enterically coated. This inventive approach ensures targeted delivery and enhanced efficacy of the active ingredient. The second patent builds upon the first one, emphasizing the importance of enteric coating in maximizing the benefits of 5-aminosalicylic acid capsules.

3. Company Affiliation:

Deborah currently works at Allergan Pharmaceuticals International Limited, a prominent pharmaceutical company committed to developing and commercializing innovative healthcare solutions. Allergan's dedication to excellence complements Deborah's own passion for pushing the boundaries of drug formulation and meeting the needs of patients worldwide.

4. Collaborations:

Within the cutting-edge environment of Allergan Pharmaceuticals International Limited, Deborah collaborates closely with accomplished colleagues, Emma Boyd and Catherine Coulter. This synergistic teamwork enables the exchange of ideas and expertise, fostering a culture of innovation and continuous improvement within the company. Together, they aim to create new and improved pharmaceutical products that positively impact patients' lives.

Conclusion:

Deborah Leigh Caldwell's inventiveness in the field of pharmaceutics is evident through her patents for 5-aminosalicylic acid capsule formulations. Her work at Allergan Pharmaceuticals International Limited, accompanied by collaborations with Emma Boyd and Catherine Coulter, reflects her commitment to advancing drug delivery systems and improving patient outcomes. As Deborah continues to contribute to the realm of pharmaceutics, her inventions and patents will undoubtedly shape the future of the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…